登录免费注册

Zhejiang Huahai Pharmaceutical

✓ 已认证供应商

Taizhou, China · 出口市场: CN,EU,WHO

4.0(1)

认证于 2026年8月9日

产品

4

生产基地

1

Zhejiang Huahai Pharmaceutical operates GMP-certified manufacturing facilities producing APIs and intermediates for regulated markets.

★ 评价 (1)

Regulatory history

No regulatory action on record

Sourced from openFDA and the EudraGMDP register — not self-declared by the supplier.

Nothing on record for this organisation.

Performance on PharmaLink

1 of 9 metrics have enough data

On-time delivery

Not enough data

No completed orders yet

Response rate

Not enough data

Only 4 inquiries — too few to rate

Answered within 24h

Not enough data

Only 4 answered inquiries — too few to rate

Quote win rate

Not enough data

Only 4 quotes submitted — too few to rate

Dispute rate

Not enough data

No completed orders yet

Repeat buyer rate

Not enough data

Only 2 buyers — too few to rate

Completed orders

0

On PharmaLink

Average order value

Not enough data

No completed orders yet

Time on PharmaLink

2m

Joined 2026-08-09

These measure activity on PharmaLink only, not the supplier’s whole business. Rates are withheld below five samples — one delivery on time is one delivery, not a 100% record.

Commercial terms

Incoterms offered
CIF · CIP · DDP · DPU · FOB · FOB TaizhouUsed on closed deals: FOB
Payment terms
30% advance, 70% against BL
Standard lead time
2–3 weeks
Lowest minimum order
1 kgAcross live listings; per-product MOQ may be higher.
Samples
Not offered
Cold chain
ambient · refrigerated

Terms are supplier-stated defaults. The binding terms are the ones on a quote you accept.

认证证书

认证证书StatusExpirySource
NMPA✓2028年8月NMPA portal
EU GMP✓2028年1月EudraGMDP
WHO PQ✓2028年5月WHO PQ list
Manufacturing licence (Form 25/28)✓2029年8月State FDA register

生产基地

厂址FDA FEI 编号GMP 状态最近一次检查产能
Taizhou Unit-1Taizhou, China · manufacturing3005512874
—
——

关键联系人

请以已认证买家身份登录以查看商务邮箱。

产品

评价4.0(1)